A graduate who co-founded a company while studying at university could become a multi-millionaire after it was sold in a deal potentially worth £623m. Dr Harry Destecroix, 31, co-founded Ziylo while studying for his PhD at the University of Bristol four years ago. It created a new technology which can be developed to treat diabetes more effectively. Pharmaceutical giant Novo Nordisk’s purchase means it now has full rights to develop glucose responsive insulins. https://www.bbc.co.uk/news/uk-england-bristol-45268904